The SLC14A1 gene helps move urea, a waste product, across cell membranes, especially in red blood cells, the kidneys, and the bladder. In medicine, this gene is important because it determines the Kidd blood group, which matters for safe blood transfusions. If it does not work normally, the body may handle urine concentration less efficiently. Some variants in the SLC14A1 gene have also been linked to differences in bladder cancer risk, but they do not by themselves diagnose cancer.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the instructions for producing proteins, the parts of cells that do the work. Other genes mainly direct when certain processes happen, where they happen, and how strongly they are carried out. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this topic in greater depth, you can read more in the LearnHub.
Overview
SLC14A1Gene function
What if the gene works
The SLC14A1 gene helps move urea, a waste product, across cell membranes. This supports urine concentration in the kidneys and contributes to the Kidd blood group marker on red blood cells.
Risk
What if the gene does not work
Changes in the SLC14A1 gene can range from mild to more severe. More disruptive variants may weaken kidney urea transport, reducing the ability to concentrate urine, and can alter Kidd blood group antigens, which matters for transfusion matching.
Treatment
What does that mean for your treatment
There is no SLC14A1-specific drug treatment. Its main clinical relevance is transfusion management: people with loss-of-function variants that cause the Kidd-null blood type may need carefully matched blood to reduce the chance of hemolytic transfusion reactions.
Gene function
What if the gene works
Your body uses the SLC14A1 gene to move urea, a normal waste product from protein breakdown, across certain cell membranes. This is especially important in the kidneys and red blood cells. When this system works well, urea shifts to the right place at the right time, helping with fluid balance and everyday waste handling.
The SLC14A1 gene makes a transport protein that moves urea, a waste product from protein breakdown, across certain cell membranes. This allows urea to pass in and out of cells in a controlled way.
In the kidneys, this transporter helps recycle urea through the inner part of the kidney. That helps the kidneys concentrate urine and hold on to water when your body needs it.
In red blood cells, the protein lets urea move quickly between the blood and nearby tissues. This helps blood carry and release urea smoothly as it circulates.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help create normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC14A1 gene can change the shape, stability, or delivery of its urea transporter protein to the cell surface, reducing how well cells move urea, a waste product. This is how variants in the SLC14A1 gene affect protein function: some milder changes leave partial transport activity, while more severe variants can sharply reduce or completely stop transport. In some cases, variants also alter the Kidd blood group marker carried on the same protein.
How variants are linked to conditions
The best-established conditions linked to SLC14A1 gene variants involve the Kidd blood group, which can affect blood transfusion compatibility and, less often, hemolytic disease of the fetus and newborn. Rare inherited variants can cause the Kidd-null blood type, and some people with this pattern have a mild reduced ability to concentrate urine. Common variants in the SLC14A1 gene have also been associated with bladder cancer risk in population studies, but they do not make cancer certain.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, one well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce health risk related to the SLC14A1 gene itself. Some changes in this gene have been linked with differences in bladder cancer risk in research studies, but overall risk still depends on many other genetic, environmental, and lifestyle factors.
Inheritance of SLC14A1 variants
For families asking how SLC14A1 variants are inherited, the best-established pattern is autosomal codominant inheritance for Kidd blood group traits linked to the SLC14A1 gene. This means you inherit one copy of the SLC14A1 gene from each parent, and both copies can shape your blood group result. A child may receive either parental version, so brothers and sisters can have different Kidd blood group types. Because SLC14A1 is on chromosome 18, this inheritance pattern is the same for males and females.
What does my SLC14A1 result mean for my family?
There isn't yet a broadly confirmed inherited pattern for SLC14A1 that is tied to a single, well-defined health condition in the way some other genes are. If you have a specific SLC14A1 result and want to know what it could mean for close relatives, a doctor or genetic counselor can explain it in the context of your family and the exact result.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry variants in the SLC14A1 gene, genetic testing uses DNA from a blood sample or cheek swab. A lab reads the gene’s sequence and reports whether any known variants are present.
When should I consider getting a genetic test?
Consider SLC14A1 testing if you have had an unusual reaction to a blood transfusion, trouble finding compatible blood, or lab results suggesting a rare Kidd blood type. It can help clarify your blood type markers and support safer transfusions, especially if this pattern runs in your family.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but the amount it explains depends on the condition and on the kind of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and is most helpful when considered together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts on its target. This helps explain why the same medication may work well for one person, do less for another, or cause more side effects in someone else. These differences are common and are one part of the bigger picture, along with age, kidney and liver function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medication. It focuses on the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can help support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the SLC14A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so questions about new symptoms, side effects, or changes in treatment are best discussed with your doctor.
History
The SLC14A1 gene entered medicine through the history of the Kidd blood group system, first recognized in the early 1950s after an unusual blood antibody was identified in a woman named Mrs. Kidd. That discovery helped doctors understand a new cause of transfusion reactions and newborn blood incompatibility. Initially understood only through visible traits, later recognized as tied to a specific gene, the Kidd blood group became an important link between blood typing and genetics. In later decades, researchers mapped these blood group traits to the SLC14A1 gene and clarified why some people test as Jk(a), Jk(b), or the very rare Kidd-null type. These historical steps shaped today’s understanding of blood group matching in transfusion medicine.